Dr. Powell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1051 W Rand Rd
Ste 103
Arlington Heights, IL 60004Phone+1 847-259-5900Fax+1 847-499-3089
Education & Training
Advocate Health Care/Advocate Children's Hospital (Park Ridge)Residency, Pediatrics, 2000 - 2003
Rush Medical College of Rush University Medical CenterClass of 2000
Certifications & Licensure
IL State Medical License 2000 - 2026- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 214 citationsNonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on OutcomeYvette L. Kasamon, Leo Luznik, Mary S. Leffell, Jeanne Kowalski, Hua Ling Tsai
Biology of Blood and Marrow Transplantation. 2010-04-01 - 1376 citationsHLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideLeo Luznik, Paul O'Donnell, Heather J. Symons, Allen R. Chen, M. Susan Leffell
Biology of Blood and Marrow Transplantation. 2008-06-01 - 132 citationsInhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT ...Robert Leone, Im Meng Sun, Min Hee Oh, Im Hong Sun, Jiayu Wen
Cancer Immunology, Immunotherapy. 2018-06-19
Press Mentions
What Happens When A Kid Puts Magnets up Their NoseNovember 16th, 2017
Grant Support
- Egr-2/3 And NAB2 In T Cell Anergy And ActivationNational Cancer Institute2003–2012
- Transplantation Tolerance And Immune Function Following Mtor Inhibition.National Institute Of Allergy And Infectious Diseases2010–2011
- Sprouty1 Is A Novel Negative Regulator Of T Cell ActivationNational Institute Of Allergy And Infectious Diseases2009–2011
- A Central Role For Mtor In Determining T Cell Activation Versus ToleranceNational Institute Of Allergy And Infectious Diseases2009–2011
- A2A Receptor Engagement Promotes T Cell ToleranceNational Cancer Institute2006–2010
- Sprouty1 Is A Novel Negative Regulatorof T Cell ActivationNational Institute Of Allergy And Infectious Diseases2008
- Induction And Maintenance Of T Cell AnergyNational Institute Of Allergy And Infectious Diseases2001–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
